Physician profile
Khalid Noori
NPI 1023106838
$3,943.54
in general payments reported to CMS, 2019-2025
48 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2020: $148 · 2021: $305 · 2022: $831 · 2023: $431 · 2024: $709 · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,373.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $450.51 | 2021-2025 | Farapulse, Watchman Access System |
| Novo Nordisk INC | $381.04 | 2019-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $297.89 | 2020-2025 | Airsupra, Breztri, Farxiga |
| Acadia Pharmaceuticals INC | $211.23 | 2022-2023 | Nuplazid |
| Janssen Pharmaceuticals, INC | $206.39 | 2019-2022 | |
| Abbvie INC. | $203.32 | 2022-2023 | |
| Smith+Nephew, INC. | $198.88 | 2021-2025 | Renasys Touch |
| Esperion Therapeutics, INC. | $149.59 | 2021 | |
| Exact Sciences Corporation | $125.63 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $124.99 | 2025 | Repatha |
| Medtronic, INC. | $123.02 | 2021-2024 | Closurefast |
| Sumitomo Pharma America, INC. | $114.52 | 2024-2025 | Gemtesa, Myfembree |
| Abbott Laboratories | $100.18 | 2019-2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $95.21 | 2024-2025 | Rexulti, Nuedexta |
| Penumbra, INC. | $71.50 | 2025 | Indigo System |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.93 | 2019-2024 | Jardiance, Synjardy |
| Mimedx Group, INC. | $65.34 | 2024-2025 | |
| Lundbeck LLC | $62.05 | 2023-2025 | Rexulti |
| Glaxosmithkline, LLC. | $58.38 | 2019-2024 | Arexvy, Trelegy Ellipta |
| Pfizer INC. | $52.68 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.43 | 2025 | |
| Novartis Pharmaceuticals Corporation | $49.37 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $48.91 | 2024 | |
| Neurelis, INC. | $45.31 | 2022-2025 | Valtoco |
| Cook Medical LLC | $40.28 | 2023-2025 | Rosen, Zilver Ptx |
| Angiodynamics, INC. | $37.52 | 2023 | Auryon Laser System 100-120 Vac |
| Amarin Pharma, INC. | $35.24 | 2019 | |
| Bard Peripheral Vascular, INC. | $34.44 | 2025 | Denali Vena Cava Filter |
| Kerecis Limited | $32.46 | 2021 | |
| Indivior INC. | $26.17 | 2025 | Sublocade |
| Baxter Healthcare | $25.79 | 2024 | Hillrom - Retinavue 700 Imager |
| Advanced Oxygen Therapy INC. | $25.45 | 2022 | |
| Lilly USA, LLC | $25.35 | 2024 | Jardiance |
| Avanir Pharmaceuticals, INC. | $24.87 | 2022 | |
| Renalytix Ai, INC. | $24.83 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Davol INC. | $24.57 | 2025 | Ventralight St |
| Ani Pharmaceuticals, INC. | $24.06 | 2025 | Purified Cortrophin Gel |
| Zimmer Biomet Holdings, INC. | $23.24 | 2022 | |
| Ascensia Diabetes Care US INC. | $22.91 | 2023 | |
| Misonix INC | $21.85 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.98 | 2023 | |
| Daiichi Sankyo INC. | $20.52 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.04 | 2025 | Caplyta |
| Ardelyx, INC. | $18.79 | 2025 | Ibsrela |
| Tactile Systems Technology INC | $17.52 | 2025 | Nimbl, Flexitouch Plus |
| Paratek Pharmaceuticals, INC. | $16.47 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $13.51 | 2020 | |
| Zyla Life Sciences, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Noori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.